Anuloma Viloma Timer
Men’s Health Month opens on June 1. The 2026 theme is “Partners in Care: For Better Lifespans Across the Lifespan.” That framing is more interesting than it sounds, because the gap between male and female life expectancy in most developed countries is now widening, not closing, and the largest single driver of the gap is cardiovascular disease.
Most men know their weight. Fewer know their resting blood pressure. Fewer still know their heart rate variability.
This piece is about a 2025 randomised controlled trial that looked at what happens when you add fifteen minutes of alternate nostril breathing to standard care for adult men with stage-one hypertension. The number that came out of it is worth understanding before the cardiology appointment, not after.
The trial
The study was published in the Indian Heart Journal in April 2025, indexed on PubMed Central as PMC11996816. The design was straightforward. Adult patients with stage-one hypertension already on standard antihypertensive medication were randomised into two groups. One group continued their standard care. The other added Nadi Shodhana, twenty minutes per day, six days per week, for eight weeks. Practice was supervised at baseline and self-administered for the remainder.
The primary outcome was systolic blood pressure. Secondary outcomes included diastolic pressure, heart rate variability markers, and a perceived stress measure.
The intervention group showed a statistically significant reduction in systolic blood pressure compared to the control. Heart rate variability improved on both time-domain and frequency-domain markers, with SDNN rising and the LF/HF ratio shifting toward parasympathetic dominance. Perceived stress dropped. Adherence was good. There were no adverse events.
The trial is not the first to look at Nadi Shodhana and blood pressure. There is a substantial older literature, much of it small, much of it from Indian university teaching hospitals, going back two decades. This one is more recent, methodologically tighter, and added on top of pharmacological care rather than tested instead of it. That last point matters because it is closer to how the practice would actually be used.
Why the autonomic system is the right place to look
Hypertension is sometimes treated as a plumbing problem. Tight pipes, hard pumping, raise the pressure. The pharmacological tools work on the plumbing layer, dilating vessels or lowering cardiac output. They work, and they are not the subject of this piece.
The autonomic nervous system is the layer above the plumbing. Sympathetic tone constricts vessels and raises heart rate. Parasympathetic tone, mediated primarily through the vagus nerve, does the opposite. Chronically elevated sympathetic tone is one of the upstream contributors to essential hypertension. It is not the only one. It is a real and modifiable one.
The breath is one of the few autonomic functions you can voluntarily control. Heart rate adapts to breath rate within seconds. Slow nasal breathing, particularly with longer exhales and held pauses, biases the system toward parasympathetic dominance. This has been the working mechanism in slow-paced breathing research for thirty years.
What Nadi Shodhana adds to generic slow nasal breathing is bilateral alternation and a structural pause. The bilateral alternation appears to engage lateralised autonomic effects (this is the same mechanism the popular “left-brain, right-brain” framing oversimplifies). The pause, kumbhaka, is the phase where heart rate variability peaks within the breath cycle and the vagal brake is most engaged.
You are not just slowing the breath. You are walking the autonomic nervous system through a structured sequence.
The first-session piece
There is a smaller study (PMC12331837, Springer 2025) that recruited 40 adults naive to pranayama and ran them through a single 15-minute Nadi Shodhana session. Heart rate variability markers shifted toward parasympathetic dominance immediately. Systolic blood pressure dropped within the same session.
This is not a long-term claim. It is a single-session physiological response. The point is that the response is fast. You do not need to be a long-term practitioner to begin observing the shift. The autonomic nervous system responds the first time you use the practice correctly.
This matters for Men’s Health Month framing because the most common reason men do not start a breathwork practice is the perception that the payoff is months away. The first-session data says otherwise. The full cardiovascular benefit accrues over weeks. The first response is immediate.
What the trial does not say
A few things to keep clear.
The trial did not show that Nadi Shodhana replaces antihypertensive medication. Nobody in the study stopped their medication. The intervention was additive. If you are on hypertension medication, the appropriate conversation is with your cardiologist, not with a blog.
The trial was not blinded in the way drug trials are blinded. Breathing practices are difficult to placebo-control. The HRV measures are objective and physiological, which strengthens the result, but the perceived stress measure is by definition self-reported.
The effect size is meaningful but is not magic. It is in the range of a low-dose pharmacological adjunct. The value is that it has no side effects, costs nothing, and addresses the autonomic upstream rather than the vascular downstream.
How to actually use it
The protocol used in the trial was twenty minutes per day, six days per week. That is roughly equivalent to four rounds of the standard 1:4:2 ratio practice (four-count inhale, sixteen-count hold, eight-count exhale, alternating nostrils). At that ratio, each round runs roughly five minutes.
The cognitive load of counting the ratios while alternating nostrils is the main reason adherence drops off in unsupported practice. The held pause is the longest phase and the easiest to truncate by accident. A timer that handles the counts is the difference between a practice that lasts a week and a practice that lasts the eight weeks the trial required.
The trial used twenty minutes. The single-session study used fifteen. If you are starting, fifteen minutes a day, six days a week, is a reasonable entry point. The structural design of the practice (the kumbhaka pause is the longest phase, not an afterthought) is what produces the autonomic shift. Get the structure right and the dose is forgiving.
This is the practice. Not a generic breathing exercise. A specific, structured, ratio-based pranayama with a recorded effect on a measurable cardiovascular outcome.
Anuloma Viloma Timer is free on the App Store. No subscription necessary.